Kranda v. Houser-Norborg Medical Corp.
419 N.E.2d 1024, 1981 Ind. App. LEXIS 1399 (1981)
Premium Feature
Subscribe to Lexplug to listen to the Case Podcast.
Rule of Law:
The Indiana Medical Malpractice Act is constitutional, and its provisions allowing medical review panel members to testify and admit individual opinions (even if based on consultations with other medical authorities) are permissible. To establish a lack of informed consent or apply res ipsa loquitur in medical malpractice, expert medical testimony is generally required to define the standard of care and show a causal link between a breach and injury.
Facts:
- In October 1975, Mary Kranda consulted Dr. Keim Houser, an obstetrician-gynecologist, regarding problems with vaginal warts and a Bartholin cyst.
- Dr. Houser knew Kranda had Crohn’s disease, which had led to previous surgeries and numerous hospitalizations.
- After several attempts to treat the warts with medication, Dr. Houser recommended surgical removal of the warts, and it was later decided the Bartholin cyst would be removed during the same surgery.
- On January 28, 1976, Dr. Houser performed a preoperative examination and discussed removing the cyst, but did not discuss Kranda's Crohn’s disease or its associated surgical risks with her.
- On February 6, 1976, Dr. Houser performed the surgery, during which he removed the Bartholin gland and cyst, and recognized a small tear in Kranda's rectal mucosa due to tissue fibrosis and scarring, which he repaired with sutures.
- That evening, Dr. Houser informed Kranda of the rectal entry and repair, stating he did not expect any problems.
- On February 10, 1976, Kranda was released, but that evening experienced gas and fecal matter escaping from the incision.
- Kranda was subsequently diagnosed with a fistula and underwent a temporary colostomy in Chicago, followed by further surgeries for a bowel obstruction (due to Crohn's) and an ileostomy, eventually resulting in a complete colostomy.
Procedural Posture:
- Mary C. Kranda filed a medical malpractice action against Houser-Norborg Medical Corporation and Dr. Keim Houser, M.D. in the trial court (court of first instance).
- Pursuant to the Indiana Medical Malpractice Act, the claim was submitted to a medical review panel, which issued expert opinions.
- The trial court granted judgment on the evidence in favor of Dr. Houser as to the issue of informed consent.
- The trial court granted judgment on the evidence in favor of Houser-Norborg Medical Corporation as to its liability.
- A jury returned a verdict in favor of Dr. Houser on the remaining claims.
- Judgment was entered by the trial court in accordance with the jury's verdict and the prior judgments on the evidence.
- Mary C. Kranda (appellant-plaintiff) appealed the negative judgment to the Indiana Court of Appeals (intermediate appellate court).
Premium Content
Subscribe to Lexplug to view the complete brief
You're viewing a preview with Rule of Law, Facts, and Procedural Posture
Issue:
1. Does the Indiana Medical Malpractice Act unconstitutionally infringe upon rights or improperly delegate judicial power by requiring submission to a medical review panel, allowing panel consultations with medical authorities, and admitting individual panel opinions in court? 2. Did the trial court err in granting judgment on the evidence regarding informed consent when no expert witness testified that the specific, rare risk of rectal injury during Bartholin cyst surgery was one a physician had a duty to disclose, despite the patient's claim she would not have consented? 3. Did the trial court err in refusing to instruct the jury on res ipsa loquitur in a medical malpractice case where an unusual surgical injury occurred, but no expert testified that the injury would not ordinarily occur but for negligence, especially given the patient's complex medical history?
Opinions:
Majority - YOUNG, Presiding Judge
No, the trial court did not err in permitting medical review panel members to testify or admit their individual written opinions, nor is the Indiana Medical Malpractice Act unconstitutional. The court affirmed that the term "medical authorities" in IC 16-9.5-9-6, allowing the panel to consult with such authorities, includes both written materials and qualified individuals. Kranda's claim that she had no opportunity to cross-examine these physicians was rejected, as IC 16-9.5-9-5 provides for either party to convene the panel and question members. The panel's function is informal inquiry to form an expert opinion, not adjudication, so formal rules of evidence are not required. The court also rejected the hearsay argument for panel member opinions, citing Trinity Universal Insurance Co. v. Town of Speedway and Rosenbalm v. Winski, which permit expert witnesses to draw upon reliable sources of information, including other doctors. The Act does not require a collegial or unanimous opinion, and individual panel member opinions are admissible as part of the panel's report (IC 16-9.5-9-9), with IC 16-9.5-9-10 contemplating the possibility of no majority opinion. The court affirmed the constitutionality of the Indiana Medical Malpractice Act, reiterating that the Indiana Supreme Court's decision in Johnson v. St. Vincent’s Hospital, Inc., 404 N.E.2d 585 (Ind. 1980), was dispositive of Kranda's various constitutional challenges, including arguments regarding 'chilling effect,' cost and delay, quasi-judicial procedures, delegation of judicial power, and separation of powers doctrine. No, the trial court did not err in withdrawing the issue of informed consent from the jury's consideration. An action based on informed consent is one of negligence, requiring duty, breach, and proximate cause. Indiana law requires a physician to make a "reasonable disclosure of material facts." However, expert medical testimony is generally required to establish the content of such reasonable disclosure, unless the situation is clearly within a layman's comprehension. Bartholin cyst surgery is not such a matter. Kranda failed to present expert medical testimony indicating that a reasonable disclosure would include the risk of rectal injury, as all medical testimony suggested such an injury was unexpected. Although Kranda testified she would not have consented had she known of this specific risk, there was no evidence that revelation of any other risk would have changed her consent, and no duty to disclose the specific, unexpected risk was established. Without proof that the physician's failure to inform about a duty-bound risk proximately caused Kranda to undergo the treatment, the element of proximate cause was not met, rendering judgment on the evidence proper. No, the trial court did not err in refusing to instruct the jury on res ipsa loquitur. While the doctrine applies when an injury is of a character that would not occur but for negligence and is caused by an instrumentality within the physician's exclusive control, expert testimony is required when the conclusion is not within common knowledge. Here, although the injury occurred under Dr. Houser's control and experts testified they had not seen such an injury in their combined experience, no expert testified that this injury would not ordinarily occur but for negligence, especially in a complex case involving a patient with Crohn's disease, prior surgery, and scar tissue. Thus, there was no evidence to support the conclusion that the injury was one that would not ordinarily occur in the exercise of due care.
Analysis:
This case serves as a foundational precedent for the application and constitutionality of the Indiana Medical Malpractice Act, solidifying the role and admissibility of medical review panel opinions. It establishes critical limitations on informed consent claims, mandating expert testimony to define disclosure standards and link non-disclosure to a duty-bound risk. Furthermore, the ruling clarifies the stringent requirements for applying res ipsa loquitur in complex medical procedures, emphasizing the need for expert testimony to specifically attribute a rare or unusual outcome to negligence, rather than merely to the rarity of the injury itself, especially in cases with complicating patient histories.
